When to start ART in adults? The results of HPTN 052 move us closer to a test-and-treat policy
Southern African Journal of HIV Medicine
| Field | Value | |
| Title | When to start ART in adults? The results of HPTN 052 move us closer to a test-and-treat policy | |
| Creator | Geffen, Nathan | |
| Description | When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/µl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we move to a ‘test-and-treat’ approach in which anyone who tests HIV-positive is offered ART, irrespective of their CD4 count? The recently announced results of the HPTN 052 trial take us closer, but not all the way, to a test-and-treat approach. | |
| Publisher | AOSIS | |
| Date | 2011-09-30 | |
| Identifier | 10.4102/sajhivmed.v12i3.178 | |
| Source | Southern African Journal of HIV Medicine; Vol 12, No 3 (2011); 9 2078-6751 1608-9693 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://sajhivmed.org.za/index.php/hivmed/article/view/178/299
https://sajhivmed.org.za/index.php/hivmed/article/view/178/298
|
|
ADVERTISEMENT
